阿尔茨海默病中神经炎症生物标志物及相关药物治疗研究进展OA

Alzheimer's disease(AD)is one of the most common chronic neurodegenerative disorders,characterized by a series of pathological processes.Neuroinflammation,marked by activation of the glial cell system,constitutes a key component of AD pathogenesis.Timely prevention of neuroinflammation or monitoring of inflammatory responses may serve as a prospective therapeutic approach for AD.This article reviews the potential application value of neuroinflammation biomarkers in early diagnosis of AD and their clinical significance in disease progression,and summarizes the current therapeutic research progress on AD-related neuroinflammation drugs,with the aim of providing reference for subsequent research and clinical practice in this field.